The Need for Mixed-Effects Modeling with Population Dichotomous Data Ikuko YanoStuart L. BealLewis B. Sheiner OriginalPaper Pages: 109 - 128
Population Pharmacokinetic–Pharmacodynamic Modeling of Filgrastim (r-metHuG-CSF) in Healthy Volunteers Bing WangThomas M. LuddenLorin K. Roskos OriginalPaper Pages: 321 - 342
Selecting Reliable Pharmacokinetic Data for Explanatory Analyses of Clinical Trials in the Presence of Possible Noncompliance Jianfeng LuJean-Michel GriesLewis B. Sheiner OriginalPaper Pages: 343 - 362
Impact of Pharmacokinetic–Pharmacodynamic Model Linearization on the Accuracy of Population Information Matrix and Optimal Design Yann MerléMichel Tod OriginalPaper Pages: 363 - 388
ERRATUM: “Population Pharmacokinetic Modeling of Steady State Carbamazepine Clearance in Children, Adolescents, and Adults,” by David M. Reith, Wayne D. Hooper, John Parke, and Bruce Charles OriginalPaper Pages: 413 - 413